Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions

Several clinical trials are exploring therapeutic effect of human CD34(+) cells in ischemic diseases, including myocardial infarction. Unfortunately, most of the cells die few days after delivery. Herein we show that lysophosphatidic acid (LPA)-treated human umbilical cord blood-derived CD34(+) cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostic, Ivana, Fidalgo-Carvalho, Isabel, Aday, Sezin, Vazão, Helena, Carvalheiro, Tiago, Grãos, Mário, Duarte, António, Cardoso, Carla, Gonçalves, Lino, Carvalho, Lina, Paiva, Artur, Ferreira, Lino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639756/
https://www.ncbi.nlm.nih.gov/pubmed/26553339
http://dx.doi.org/10.1038/srep16406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639756/
https://www.ncbi.nlm.nih.gov/pubmed/26553339
http://dx.doi.org/10.1038/srep16406

Ejemplares similares